VERTEX PHARMACEUTICALS INC - CALL
Historical Holders from Q1 2014 to Q4 2025
-
Type / Class
-
Equity / CALL
-
Price per share
-
$5.39
-
All holders as of 30 Sep 2025
-
Q3 2025
-
Number of holders
-
0
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
As of 30 Sep 2025,
VERTEX PHARMACEUTICALS INC - CALL has
0
institutional shareholders
filing 13F forms.
They reported no common stock holdings, but disclosed options positions.
Institutional Holders of VERTEX PHARMACEUTICALS INC - CALL across Reporting Periods
| Period |
Reported Shares, Excl. Options
|
Value, Excl. Options
|
Value Change
|
Puts Notional Value
|
Calls Notional Value
|
Price
|
Investors
|
|
2025 Q4
|
|
|
|
|
$297,000
|
$5.39
|
0
|
|
2025 Q3
|
|
|
|
|
$130,540,644
|
$391.64
|
0
|
|
2025 Q2
|
|
|
|
|
$69,508,020
|
$445.20
|
0
|
|
2025 Q1
|
|
|
|
|
$100,809,480
|
$484.82
|
0
|
|
2024 Q4
|
|
|
|
|
$121,217,970
|
$402.70
|
0
|
|
2024 Q3
|
|
|
|
|
$133,050,620
|
$465.08
|
0
|
|
2024 Q2
|
|
|
|
|
$102,693,184
|
$468.72
|
0
|
|
2024 Q1
|
|
|
|
|
$143,465,417
|
$418.01
|
0
|
|
2023 Q4
|
|
|
|
|
$215,980,194
|
$406.89
|
0
|
|
2023 Q3
|
|
|
|
|
$135,829,076
|
$347.74
|
0
|
|
2023 Q2
|
|
|
|
|
$96,473,481
|
$351.91
|
0
|
|
2023 Q1
|
|
|
|
|
$81,639,102
|
$315.07
|
0
|
|
2022 Q4
|
0
|
$0
|
-$240,000
|
|
$93,339,306
|
$288.78
|
0
|
|
2022 Q3
|
1,300
|
$240,000
|
|
|
$87,345,000
|
$289.52
|
1
|
|
2022 Q2
|
0
|
$0
|
-$234,000
|
|
$113,732,000
|
$281.79
|
0
|
|
2022 Q1
|
3,600
|
$726,000
|
+$70,000
|
|
$70,180,000
|
$260.97
|
2
|
|
2021 Q4
|
3,600
|
$655,000
|
+$382,083
|
|
$67,362,000
|
$219.60
|
1
|
|
2021 Q3
|
1,500
|
$279,000
|
+$279,000
|
|
$65,093,000
|
$181.71
|
1
|
|
2021 Q2
|
|
|
|
|
$65,066,000
|
$201.63
|
0
|
|
2021 Q1
|
|
|
|
|
$121,090,000
|
$214.89
|
0
|
|
2020 Q4
|
|
|
|
|
$33,452,000
|
$236.34
|
0
|
|
2020 Q3
|
|
|
|
|
$17,625,000
|
$144.54
|
0
|
|
2020 Q2
|
|
|
|
|
$29,379,000
|
$290.30
|
0
|
|
2020 Q1
|
|
|
|
|
$43,044,000
|
$237.94
|
0
|
|
2019 Q4
|
|
|
|
|
$36,937,000
|
$218.96
|
0
|
|
2019 Q3
|
|
|
|
|
$35,035,000
|
$169.42
|
0
|
|
2019 Q2
|
|
|
|
|
$23,521,000
|
$183.38
|
0
|
|
2019 Q1
|
|
|
|
|
$79,263,000
|
$183.95
|
0
|
|
2018 Q4
|
|
|
|
|
$40,963,000
|
$165.71
|
0
|
|
2018 Q3
|
|
|
|
|
$69,946,000
|
$192.75
|
0
|
|
2018 Q2
|
|
|
|
|
$36,320,000
|
$169.98
|
0
|
|
2018 Q1
|
|
|
|
|
$26,049,000
|
$163.08
|
0
|
|
2017 Q4
|
|
|
|
|
$26,644,000
|
$149.86
|
0
|
|
2017 Q3
|
|
|
|
|
$91,036,000
|
$152.04
|
0
|
|
2017 Q2
|
|
|
|
|
$81,599,000
|
$151.82
|
0
|
|
2017 Q1
|
|
|
|
|
$28,884,000
|
$109.35
|
0
|
|
2016 Q4
|
|
|
|
|
$15,297,000
|
$73.68
|
0
|
|
2016 Q3
|
|
|
|
|
$26,914,000
|
$87.22
|
0
|
|
2016 Q2
|
|
|
|
|
$10,483,000
|
$86.02
|
0
|
|
2016 Q1
|
|
|
|
|
$8,455,000
|
$79.50
|
0
|
|
2015 Q4
|
0
|
$0
|
-$140,000
|
|
$15,287,000
|
$125.84
|
0
|
|
2015 Q3
|
12,000
|
$140,000
|
+$140,000
|
|
$17,373,000
|
$104.14
|
1
|
|
2015 Q2
|
|
|
|
|
$14,964,000
|
$123.50
|
0
|
|
2015 Q1
|
|
|
|
|
$15,400,000
|
$117.98
|
0
|
|
2014 Q4
|
|
|
|
|
$69,267,000
|
$118.97
|
0
|
|
2014 Q3
|
|
|
|
|
$303,574,000
|
$112.31
|
0
|
|
2014 Q2
|
|
|
|
|
$317,325,000
|
$94.68
|
0
|
|
2014 Q1
|
|
|
|
|
$195,696,000
|
$70.72
|
0
|